Sinclair Pharmaceuticals Limited

Bmg Pharma S.p.a.

Marco Lucio Mastrodonato

Roberto Ciattini

Disclosed is a topical composition for the treatment of hirsutism comprising capryloyl glycine as active ingredient, mixed with dermatologically acceptable carriers.

Topical hirsutism treatment

This invention relates to topical compositions, such as creams and lotions, that comprise or consist essentially of Telmesteine, or a pharmaceutically acceptable salt thereof, as the active ingredient, and methods for their use in treating a variety of dermatological diseases and disorders, including atopic, dermatitis (eczema), allergic contact dermatitis. seborrheic dermatitis, radiation dermatitis, psoriasis, xerosis and atopy.

Topical compositions comprising telmesteine for treating dermatological disorders

The present invention relates to compositions comprising telmesteine, glycyrrhetinic acid, and a proanthocyanidin, as well as methods for using such compositions in the treatment of an inflammatory condition of the skin including, but not limited to, atopic dermatitis(eczema), allergic contact dermatitis, seborrheic dermatitis, psoriasis,and atopia, as well as treatment of an inflammatory condition of mucosae and of an inflammatory condition in the eye. The present invention also relates to compositions comprising a proanthocyanidin, glycyrrhetinic acid and telmesteine, as well as methods for using such compositions in the treatment of an inflammatory condition of the skin including, but not limited to, atopic dermatitis, allergic contact dermatitis, seborrheic dermatitis, radiation dermatitis, psoriasis,and atopia, as well as treatment of an inflammatory condition of mucosae and of an inflammatory condition in the eye.

Growing community of inventors

Milan, Italy

Marco Lucio Mastrodonato